BACKGROUND AND PURPOSE K V 7.1 voltage-gated potassium channels are expressed in vascular smooth muscle cells (VSMC) of diverse arteries, including mesenteric arteries. Based on pharmacological evidence using R-L3 (K V 7.1 channel opener), HMR1556, chromanol 293B (K V 7.1 channel blockers), stimulation of these channels has been suggested to evoke profound relaxation in various vascular beds of rats. However, the specificity of these drugs in vivo is uncertain.
Introduction
Recent data suggest that the KCNQ family of voltage-gated K + (K V 7) channels represents a new therapeutic target in cardiovascular disease (Mackie and Byron, 2008; Greenwood and Ohya, 2009; Gurney et al., 2010; Tano et al., 2014) . The K V 7 channel family is composed of five different isoforms, namely K V 7.1-5. Among them, K V 7.1 channels are highly expressed at the mRNA and protein level in different types of vessels in humans and animals (Yeung et al., 2007; Ng et al., 2011; Chadha et al., 2012) . Based on the effects of pharmacological drugs, stimulation of K V 7.1 channels has been suggested to cause profound relaxation in various vascular tissues of rats, including the aorta, mesenteric and pulmonary arteries (Chadha et al., 2012) . Immunohistochemical studies using anti-KCNQ1 antibodies indicated Kcnq1 expression in murine arteries (aortic artery), including the endothelial and smooth muscle layers, at late embryonic and fetal stages (E14.5 to E16.5) (de Castro et al., 2006) and in adult arteries (Yeung et al., 2007) . Of note, blood pressure is enhanced in Kcnq1 À/À mice (Takagi et al., 2007) . In humans, mutations in the KCNQ1 gene cause Jervell and Lange-Nielsen syndrome (Wang et al., 1996; Goldenberg et al., 2008) . A recent meta-analysis suggests a possible causative role of the KCNQ1 gene in type 2 diabetes (Liu et al., 2013) . However, it is unknown whether KCNQ1 gene products are related to vascular pathologies and/or blood pressure regulation in humans. K V 7.1 channels are expressed in vascular smooth muscle cells (VSMCs) of thoracic aorta, carotid, femoral and mesenteric arteries in mice (Yeung et al., 2007; Schleifenbaum et al., 2014) and rats (Chadha et al., 2012) . Although these channels presumably do not contribute to resting vascular tone, K V 7.1 channel activators, such as R-L3 (L-364373), were shown to be effective vasorelaxants (Chadha et al., 2012) . R-L3 responses were inhibited by blockers of K V 7.1 channels, such as HMR1556 or chromanol 293B, which suggests that KCNQ1 activation is an important mechanism underlying vascular relaxation (Chadha et al., 2012) . However, the specificity of the drugs used to target native K V 7.1 channels is unknown, since the pore-forming K V 7.1 subunit can interact with several accessory KCNE subunits, which are known to modulate the biophysical properties of K V 7 channels in vivo (Jespersen et al., 2005) . Second, these accessory subunits may influence the pharmacological properties of native, complex, multimeric K V 7.1 channels (MacVinish et al., 2001) . Therefore, the aim of this study was to test the contribution of K V 7.1 channels in the regulation of arterial vascular tone by using Kcnq1 À/À mice and pharmacological tools, such as R-L3, chromanol 293B and HMR1556. We also used a novel K V 7 channel opener, ML277, which has recently been shown to activate K V 7.1 channels in cardiomyocytes with an EC 50 of 260 nM (Mattmann et al., 2012) .
Methods

Mouse model
All animal care and experimental procedures followed American Physiological Society guidelines and were approved by the local authorities (Landesamt für Gesundheit und Soziales Berlin, LAGeSo). Animal studies are reported in compliance with the ARRIVE guidelines (Kilkenny et al., 2010; McGrath and Lilley, 2015) . Animals were housed in individually ventilated cages under standardized conditions with an artificial 12 h dark-light cycle with free access to water and food. We used Kcnq1 À/À mice (C57BL/6 background) with targeted disruption of exon 2 of the Kcnq1 gene (Casimiro et al., 2001) . Heterozygous mice were used for breeding to obtain homozygous knockout (Kcnq1 (Casimiro et al., 2001) . PCR reactions were analysed on 2% agarose gels containing ethidium bromide, visualized by exposure to ultraviolet light with DNA ladder 100 BP manufactured by PeqLab.
Quantitative real-time PCR
Experiments were performed according to MIQE guidelines (Bustin et al., 2009) . Briefly, total RNA was isolated from either
Figure 1
Original recordings showing the effects of 0.3-3 μM R-L3, 10 μM chromanol 293B, 10 μM HMR1556, 0.5 mM 4 aminopyridine (4-AP) and 10-30 μM XE991 on arterial tone of isolated mesenteric artery rings without PVAT (À) fat. Mesenteric arteries were either precontracted with 1 μM phenylephrine (PE) (A,B,C) or with 60 mM KCl (D). Effects of chromanol 293B (A) and HMR1556 (B) on arterial tone induced by PE. All vessels were from wild-type (Kcnq1 +/+ ) mice. and Kcnq1 À/À was calculated using 2 ΔΔCt method (Livak and Schmittgen, 2001 ). The following primers were used:
18s: F: 5′-ACATCCAAGGAAGGCAGCAG-3′; R: 5′-XTTTTCGTCACTACCTCCCCG-3′ Kcnq3: F: 5′-CAGTATTCGGCCGGACATCT-3′; R: 5′-GAGACTGCTGGGATGGGTAG-3′ Kcnq4: F: 5′-CACTTTGAGAAGCGCAGGAT-3′; R: 5′-CCAGGTGGCTGTCAAATAGG-3′ Kcnq5: F: 5′-CCTCACTACGGCTCAAGAGT-3′; R: 5′-TTAAGTGGTGGGGTGAGGTC-3′
Wire myography
Mesenteric or renal arteries were removed immediately after killing the mice with isoflurane anaesthesia, quickly transferred to cold (4°C), oxygenated (95% O 2 /5% CO 2 ) physiological salt solution (PSS) containing (in mmol L À1 ) 119 NaCl, 4.7 KCl, 1.2 KH 2 PO 4 , 25 NaHCO 3 , 1.2 Mg 2 SO 4 , 11.1 glucose, 1.6 CaCl 2 and dissected into 2 mm rings. The perivascular fat (PVAT) and connective tissue was either intact "(+) fat" or removed "(À) fat" from each ring without damaging adventitia. For experiments involving endothelium-denuded arteries, a 1 mL air bubble was used to disrupt the endothelium and removal of a functional endothelium was confirmed by absence of a vasodilatory response to 10 μM ACh. Each ring was positioned between two stainless steel wires (diameter 0.0394 mm) in a 5 mL organ bath of a Mulvany Small Vessel Myograph (DMT 610 M; Danish Myo Technology, Denmark). The organ bath was filled with PSS. The bath solution was continuously oxygenated with a gas mixture of 95% O 2 and 5% CO 2 and kept at 37°C (pH 7.4) (Fésüs et al., 2007) . The mesenteric and renal rings were placed under a tension equivalent to that generated at 0.9 times the diameter of the vessel at 100 mm Hg by stepwise distending the vessel using LabChart DMT Normalization module. This normalization procedure was performed to obtain the passive diameter of the vessel at 100 mm Hg (Fésüs et al., 2007) . The software Chart5 (AD Instruments Ltd. Spechbach, Germany) was used for data acquisition and display. After 60 min, incubation arteries were pre-contracted either with isotonic external 60 mM KCl or 1-3 μM phenylephrine until a stable resting tension was acquired. 
Isolation of arterial VSMCs
VSMCs from mesenteric arteries were isolated as described Plüger et al., 2000; Schleifenbaum et al., 2014) . Briefly, the first order of mesenteric or main renal arteries was removed and quickly transferred to cold (4°C) 
Electrophysiology
Voltage dependent potassium (K V ) currents were measured in the conventional whole-cell configuration of the patchclamp technique at room temperature as previously described (Gollasch et al., 1996; Essin et al., 2007; Schleifenbaum et al., 2014) . Patch pipettes (resistance, 3-5 MΩ) were filled with a solution containing (in mM): 130 KCl, 1 MgCl 2 , 3 Na2-ATP, 0.1 Na3-GTP, 10 HEPES and 5 EGTA (pH 7.2; Yeung and Greenwood, 2005) . The external bath solution contained (in mM): 126 NaCl, 5 KCl, 1 MgCl 2 , 0.1 CaCl 2 , 10 HEPES, 11 Glucose (pH 7.2; Yeung and Greenwood, 2005) . Holding potential was À60 mV. Whole cell currents were recorded using an Axopatch 200B amplifier (Axon Instruments/Molecular Devices, Sunnyvale, CA, USA) or an EPC 7 amplifier (List, Darmstadt, Germany) and digitized at 5 kHz, using a Digidata 1440A digitizer (Axon CNS, Molecular Devices) and pClamp software versions 10.1 and 10.2.
Data and statistical analysis
These studies comply with the recommendations on experimental design and analysis in pharmacology (Curtis et al., 2015) . Data are presented as mean AE SEM. EC 50 values were calculated using a Hill equation: T = (B 0 ÀBe)/(1 + ([D]/ EC 50 ) n ) + Be, where T is the tension in response to the drug (D); Be is the maximum response induced by the drug; B 0 is a constant; EC 50 is the concentration of the drug that elicits a half-maximal response (Bychkov et al., 1998) . Curve fittings and data analysis were done by GraphPad6 (Software, La Jolla California USA) using nonlinear regression. Statistical significance was determined by t-test or ANOVA with multiple comparison by Holm-Sidak method. The post hoc tests were run only if F achieved P < 0.05, and there was no statistical significant variance in homogeneity. Extra sum-of-squares F test was performed for comparison of concentration-response curves. P values <0.05 were considered statistically significant; n represents the number of animals used; data from multiple rings, multiple cells from the same animal were averaged and treated as a single n. The data analyst was blinded, whereas blinding for the operator was not possible due to the shaker-waltzer phenotype of mice (Video S8). The data and statistical analysis comply with the recommendations on experimental design and analysis in pharmacology (Curtis et al., 2015) .
Materials
All salts and other chemicals were obtained from SigmaAldrich (Germany) or Merck (Germany). All drugs were freshly dissolved in the day of each experiment accordingly to the material sheet. When DMSO was used as solvent, maximal DMSO concentration after application did not exceed 0.5%. The following concentration of drugs were used: phenylephrine (Sigma Aldrich) ranged from 0.1 to 100 μM, retigabine (Valeant Research North America) from 0.01 to 100 μM, R-L3 (Merck) from 0.3 to 10 μM, ML277 (Sigma Aldrich) from 0.1 to 10 μM, 30 μM XE991 (Tocris), 10 μM chromanol 293B (Sigma Aldrich), 0.5 mM 4-aminopyridine (4-AP; Sigma Aldrich). KCNQ1/KCNE1 subunits are blocked by chromanol 293B with EC 50~7 μM; whereas homomeric KCNQ2, KCNQ3, KCNQ4 and heteromeric KCNQ2/KCNQ3 channels are only slightly blocked by 100 μM (Lerche et al., 2007) . Chromanol 293B is also known as (3R,4S)-293B or 3S,4R-293B (Seebohm et al., 2001) . XE991 was found to inhibit either K V 7.1 homomeric or K V 7.1/KCNE channels with IC 50~0 .8 μM and 11.1 μM respectively (Wang et al., 2000) . As a pan KCNQ inhibitor, XE991 also inhibits KCNQ2/3 channels (EC 50~1 μM) (Wang et al., 1998) , KCNQ4 (EC 50~5 .5 μM) (Søgaard et al., 2001 ) and KCNQ5 (EC 50~6 5 μM) (Schroeder et al., 2000) . 10 μM HMR1556 is known to inhibit 97% of I Ks current (mainly composed of K V 7.1/KCNE channels) (Bosch et al., 2003) . ML277 is a potent activator of KCNQ1 with EC 50 260 nM and >100-fold selective versus KCNQ2 and KCNQ4 channels (Mattmann et al., 2012) . Retigabine is an activator of the KCNQ2/3 (EC 50 5.2 μM) (Main et al., 2000) and KCNQ3/KCNQ5 channels (EC 50 1.4 μM) (Wickenden et al., 2001) .
Results
Failure of K V 7.1 channel blockers to reverse arterial relaxation induced by R-L3
First, we tested the vasodilatory effects of R-L3, which supposedly acts through activation of K V 7.1 channels. R-L3 produced concentration-dependent relaxation of murine mesenteric arteries pre-contracted with 1 μM phenylephrine ( Figures 1A,B,C and 2A,B) . Both chromanol 293B and HMR1556 (K V 7.1 channel blockers) on the contrary did not affect contractions induced by 1 μM phenylephrine ( Figure 1A ,B) (increase by 8.4 AE 4.3%, n = 5, P > 0.05, paired t-test; increase by À7.3 AE 3.8%, n = 5, P > 0.05, paired t-test, respectively). Neither 10 μM chromanol 293B ( Figure 1A ), 10 μM HMR1556 ( Figure 1B ), 30 μM XE991 nor 0.5 mM 4-AP ( Figure 1C ) reversed R-L3-induced relaxations of the murine mesenteric rings (but see Figure 3 for rat mesenteric arteries). Pretreatment of the murine mesenteric arteries with 10 μM chromanol 293B did not prevent relaxation by R-L3 ( Figure S1A ). Similar results were obtained in rat mesenteric arteries ( Figure S1B) . Interestingly, the resting tone of murine mesenteric arteries was not affected by K V 7.1 channel blockade, that is neither by 10 μM chromanol 293B (increase by À0.4 AE 0.2%, n = 5, P > 0.05, paired t-test) nor by 10 μM HMR1556 (increase by À0.2 AE 0.1%, n = 5, P > 0.05, paired t-test). Additionally and similarly to the mice, the resting tone of rat mesenteric arteries was not affected by K V 7.1 channel blockade with 10 μM chromanol 293B (increase by À0.5 AE 0.3%, n = 5, P > 0.05, paired t-test).
Next, we aimed to determine whether the R-L3 effects rely on K + channel activation through experiments using 60 mM KCl-induced contractions, which are largely determined by Ca 2+ influx through L-type Ca v 1.2 channels (Moosmang et al., 2005; Essin et al., 2007) . Importantly, R-L3 produced similar concentration-dependent relaxation in mesenteric rings regardless of whether they were pre-contracted with KCl or PE ( Figures 1D and 2A) . Similar results were also obtained in renal arteries ( Figure S2 ). A total of 30 μM XE991 was unable to reverse R-L3-induced relaxations of rings precontracted with KCl ( Figure 1D ). R-L3 produced normal relaxations in arterial rings, from Kcnq1 À/À mice and the EC 50 values were~1.4 μM in rings from both Kcnq1 +/+ and Kcnq1 À/À mice (Figure 2A,B) . The relaxant effects of R-L3 were independent of the endothelium ( Figure S3A ) (see also Figure  S3B for similar results in rat mesenteric arteries). Our data suggests that R-L3, a supposed K V 7.1 channel activator, did not induce relaxations of murine mesenteric arteries through activation of K V 7.1 channels.
Effects of ML277, another activator of K V 7.1 channels
In order to better understand the possible contribution of K V 7.1 channels in vasoregulation, we studied the vasodilatory effects of ML277, a potent activator of K V 7.1 channels EC 50 , (260 nM) (Mattmann et al., 2012) . Studies suggest that it changes the conformational dynamics of the K V 7.1 pore and/or global motions in the channel, including regions critical for K V 7 gating transitions (Xu et al., 2015) . In our experiments, ML277 induced relaxation of mesenteric arteries only at high concentrations, EC 50~1 00 μM ( Figure 2D , Figure S4 ). These effects were not different between arterial rings from wild-type and Kcnq1 À/À mice and may have occurred due to activation of other K V 7 channels (Mattmann et al., 2012) .
Anti-contractile effects of PVAT
The PVAT produces endothelium-independent relaxation by opening VSMC K V channels, which can be blocked by the pan K V 7 channel blocker XE991 and depends on the release of adipocyte-derived relaxing factor (ADRF) (Gollasch, 2012; Tano et al., 2014) . To test whether K V 7.1 channels play a role in these effects, we performed a series of experiments using K V 7.1 channel inhibitors and arteries from Kcnq1 +/+ and BJP D Tsvetkov et al.
Kcnq1
À/À mice (Figure 4 ). Mesenteric arteries were prepared either (+) fat or (À) fat (with or without PVAT). Chromanol 293B (10 μM) did not diminish the anti-contractile effects of PVAT ( Figure 4A ). Also, HMR1556 (10 μM) had no effect on phenylephrine-induced contractions of both (À) fat rings and (+) fat rings isolated from Kcnq1 +/+ mice. Moreover, HMR1556 did not diminish the anti-contractile effects of PVAT ( Figure 4B , see also Figure S5A ,B for data analysis by curve fitting using nonlinear regression). Similarly, the anticontractile effects of PVAT were normal in arteries isolated from Kcnq1 À/À mice ( Figure 3C , see also Figure S5C ,D for data analysis by curve fitting using non-linear regression). Interestingly, the activator of K V 7.2-5 channels, retigabine, induced normal concentration-dependent relaxations of Figure 2 Relaxation of (À) fat mesenteric artery rings by 0.3-3 μM R-L3, 0.1-10 μM ML 277 or 0.01-10 μM retigabine. Vessels were isolated from wild-type (Kcnq1 +/+ ) mice (A) or Kcnq1 À/À mice (B). Mesenteric arteries were precontracted by phenylephrine (PE) 1 μM (A,B) or KCl 60 mM (A). Represen-Kcnq1 À/À arteries (EC 50~1 μM) ( Figure 2C ,E,F). Taken together, our data indicate that K V 7.1 channels did not contribute to the anti-contractile effects of PVAT in our arterial rings.
Electrophysiology
Consistent with the above data indicating that K V 7.1 channels do not contribute to resting vascular tone, we found that outward voltage-dependent K V currents were normal in VSMCs isolated from Kcnq1 À/À mesenteric arteries ( Figure 5 ).
There were no differences in normalized peak K V currents (Kcnq1 +/+ , 11.3 AE 1.5 pA/pF; Kcnq1 did not observe statistically significant differences in steady state current, fast and slow time constants of current activation at +20 and +40 mV [steady state current +20 mV: Kcnq1 +/+ : 13.4 AE 1.7 pA/pF (n = 5); Kcnq1 À/À : 15.9 AE 1.6 pA/pF (n = 5); +40 mV: Kcnq1 +/+ 23.5 AE 3.1 pA/pF (n = 5); 
Discussion
Our findings provide compelling evidence that K V 7.1 channels do not contribute to vascular contraction and to the anti-contractile effects of PVAT in mouse mesenteric arteries. We observed no functional role for K V 7.1 channels in R-L3-induced relaxations. R-L3-induced relaxations fully persisted after genomic deletion of Kcnq1 and after pharmacological blockade of K V 7.1 channels by two compounds, namely HMR1556 or chromanol 293B. These conclusions were supported by findings obtained using another potent K V 7.1 channel opener, ML277. Our experiments rule out a major role for anticipated downstream targets of ADRF signalling in mesenteric vessels, namely the Kcnq1 channel gene family. Instead, our genetic mouse model revealed an unappreciated role of R-L3 in antagonizing high KCl-induced L-type Ca V 1.2 channel-dependent vascular contractions. This relaxation occurred independent of the endothelium and opening of K + channels, including K V 7.1 channels. We thus conclude that R-L3 is an inappropriate pharmacological tool for studying native vascular K V 7.1 channels in mice. per group] (C). Tension is expressed as a percentage of the steady-state tension (100%) obtained with isotonic external 60 mM KCl. *P < 0.05, significant difference between (À) fat and (+) fat rings.
K V 7.1 channels and vascular tone
According to our experimental data obtained using chromanol 293B, HMR1556 and genomic deletion, the K V 7.1 isoform is unlikely involved in the control of vascular tone of murine mesenteric arteries. Based on the effects of putative K V 7.1 channel blockers (HMR1556 and L-7) in reversing R-L3-induced relaxation, Chadha et al. proposed that K V 7.1 channels can be functionally relevant in rat mesenteric arteries (Chadha et al., 2012) . These results were reproduced in this study (Figure 3) , as the relaxant effect of R-L3 was reversed by the K V 7.1 channel blockers chromanol 293B and HMR1556 in rings from rat mesenteric arteries. However, since the observation periods in our experiments were longer than in Chadha et al., we noticed that HMR1556 produced a Figure 5 Voltage-dependent potassium K V currents in freshly isolated Kcnq1 À/À VSMCs. Original recordings of K v currents in VSMCs from Kcnq1 À/À and wild-type (WT) (Kcnq1 +/+ ) mice (A). Normalized peak K v currents (B), cell capacitance (C) and relative inhibition of K V currents by 30 μM XE991 (D). Original recordings of whole-cell K V currents in a Kcnq1 À/À VSMC in the absence (Control) and presence of 30 μM XE991 (E). Voltage clamp protocol included command voltage steps (500 ms) ranging from À100 to +60 mV in 20 mV increments. Holding potential was À60 mV; test pulse frequency was 1·20 s À1 . Current-voltage (I-V) relationship of the currents from (E) (F). n = 5 per group.
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sustained reversal of R-L3-induced relaxations only in one out of six vascular rings. Instead, HMR1556 and chromanol 293B produced rather long-lasting oscillations. This phenomenon was observed only in~50% of the vessels. In extension to the studies of Chadha et al., we explored whether blockade of K V 7.1 channels (by HMR1556) could prevent R-L3 relaxations. Our results demonstrate that K V 7.1 channel blockade (chromanol 293B) failed to prevent R-L3 relaxations ( Figure S1 ), raising doubts that R-L3 vasodilation in rat mesenteric arteries is indeed primarily caused by K V 7.1 channel openings. Finally, the K V 7.1 channel activator ML277 (EC 50 260 nM in cardiomyocytes) even at 10 μM, failed to induce relaxation in murine mesenteric arteries. Together, the data support the notion that stimulation of K V 7.1 channels cannot evoke profound relaxation in mesenteric arteries of mice. Recent data suggest a major role of K V family of K + channels as putative downstream targets of ADRF and possibly other relaxing factors released by PVAT (Schleifenbaum et al., 2010; Tano et al., 2014) . This hypothesis is supported by the blockade of the anti-contractile effects of PVAT by XE991 in rat aortas (Köhn et al., 2012) . Similar to the aorta, smaller visceral and skeletal muscle arteries, which are important in the regulation of peripheral vascular resistance, rely on opening of XE991-sensitive K V channels to mediate the paracrine effect of ADRF (Schleifenbaum et al., 2010) . In this study, we found that both chromanol 293B and HMR1556 did not affect the anti-contractile effects of PVAT. The anticontractile effects of PVAT were normal in Kcnq1 À/À vessels.
We therefore conclude that K V 7.1 channels are not the putative downstream K + channel targets of ADRF that we seek. It is likely that the ADRF effects are mediated by opening of other K v channels, for example K V 7.2-5 ( Figure 6 ). A limitation of our study is that we cannot unequivocally exclude protein overexpression of other K V channels in Kcnq1 À/À arteries to functionally compensate for the loss of Kcnq1. However, we found that the pan K V 7.2-5 channel activator retigabine (Yeung et al., 2007) produced normal relaxations in Kcnq1 À/À arteries. In addition, we also found similar expression of Kcnq3, Kcnq4 and Kcnq5 at the mRNA levels between Kcnq1 À/À and Kcnq1 +/+ mesenteric arteries ( Figure S6 ).
Kcnq2 mRNA is not detectable in this preparation, either in Kcnq1 +/+ or in Kcnq1 À/À (our data, not shown). These results argue against a significant up-regulation of K V 7.2-5 channels in these arteries. Furthermore, we found that K V currents and their block by XE991 were normal in Kcnq1 À/À VSMCs, which also argues against a contribution of functionally up-regulated K V 7.2-5 channels in the vessels of this mouse model. Moreover, another K V 7.1 channel inhibitor (L-735821) has been tested for inhibition of I Ks current in the Kcnq1 À/À mice used in our study (Knollmann et al., 2004) . Notably, L-735821 inhibited I Ks and prolonged action potential duration in Kcnq1 +/+ but not Kcnq1 À/À hearts. These data are also consistent with the idea that K V 7.2-5 channels are not up-regulated in mice deficient in K V 7.1 channels.
Specificity of R-L3
R-L3 has been used to study the functional role of K V 7.1 channels in various vascular beds and species (Seebohm et al., 2003; Chadha et al., 2012) . The results indicate that K V 7.1 channels may play a functional role in mesenteric (Chadha et al., 2012) , but not coronary arteries of rats (Khanamiri et al., 2013) . However, it is worth stressing that results with R-L3 are difficult to interpret because the enantiomeric ratio of the drug can, at least in heart (Corici et al., 2013) , affect activation kinetics of native K V 7.1 channels. Furthermore, R-L3 has been suggested to be a potent inhibitor of native vascular L-type Ca V 1.2 channels in mouse aorta (Yeung et al., 2007) , but not in rat arteries (Chadha et al., 2012) . Our genetic model supports this idea for being particularly relevant in murine mesenteric arteries ( Figure 6 ). Our conclusion is also based on similar cumulative response curves for R-L3 in both Kcnq1 À/À and Kcnq1 +/+ arteries. Moreover, the relaxant effects of R-L3 were inhibited neither by chromanol 293B, HMR1556, XE991 nor by 4-AP. Furthermore, R-L3 produced similar concentration-dependent relaxation in mesenteric rings regardless of whether they were pre-contracted with phenylephrine or KCl. Of note, tamoxifen-induced smooth muscle-specific inactivation of the L-type Ca V 1.2 Ca 2+ channel gene revealed a dominant role of these channels in KCl contractions (Moosmang et al., 2005; Essin et al., 2007) . R-L3 is thus not suitable for the study of native vascular K V 7.1 channels in mice. R-L3 may represent a more appropriate tool to study K V 7.1 channels in the rat vasculature (Figure 3) . However, it is not clear why we observed R-L3 effects, which were inhibited by HMR1556 or chromanol 293B only in 50% of the arteries. One possibility is that the enantiomeric ratio of the drugs used could play an important role. It is also well Figure 6 Schematic representation of voltage-dependent potassium (K V ) channels involved in vasoconstriction and ADRF-dependent relaxation. K + efflux through K V 7.1 channels does not seem to be involved in either process and the compound R-L3 is not specific for these channels in mice. L-type Ca v 1.2 channels play a dominant role in depolarization-induced contraction. The focus for future studies should be other K V channels and the use of selective pharmacological agents to identify the channels involved in this process. 4-AP, 4-aminopyridine.
known that KCNE subunits influence the pharmacology of K V 7.1 channels (Melman et al., 2002 (Melman et al., , 2004 , which may explain drug, tissue and species differences in vivo. As R-L3 enantiomers have opposing effects on cardiac I Ks (KCNQ1) currents (Corici et al., 2013) , K V 7.x channel subunits can hetero-oligomerize, and KCNE subunits can influence the pharmacology of KCNQ channels (Melman et al., 2002 (Melman et al., , 2004 . Further studies should clarify the putative role of KCNE subunits/isoforms in enantiomeric enrichment of R-L3 enabling the stimulatory effects of R-L3 on native K V 7.1 channels in vivo. New studies are needed to clarify a possible contribution of K V 7.1 channels in producing oscillatory contractions in the rat vasculature and the specificity of KCNQ1 modulators in these effects.
Clinical relevance
One of the most dangerous potential side effects of a drug is its pro-arrhythmic action due to cardiac QTc prolongation, in particular by KCNQ1 channel inhibition. Recently, arterial KCNQ1 (K V 7.1) channels have attracted particular attention as putative novel drug targets for regulating arterial vascular tone and systemic blood pressure. Our genetic mouse model revealed novel insights into the specificity of pharmacological drugs commonly used to characterize KCNQ1 channel function in vivo. Our data indicate that K V 7.1 channels are apparently not involved in the control of mesenteric and renal arterial tone in mice. Our studies highlight the importance of KCNQ1 channels in playing a critical role in cardiac arrhythmias, such as long QT syndrome, with negligible impact on KCNQ1 in the peripheral arteries, at least in mice.
In conclusion, our study demonstrated that K V 7.1 channels were not required for the control of arterial tone by α 1 -adrenoceptor agonists and PVAT in mesenteric and renal arteries of mice. Furthermore, R-L3, recently described as a specific activator of K V 7.1 channels, did not meet this criterion in our hands in the murine vasculature. R-L3-induced relaxations persisted after genomic deletion of Kcnq1 and following pharmacological blockade by two K V 7.1 channel blockers, HMR1556 or chromanol 293B.
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http://doi.org/10.1111/bph.13665 Figure S2 Relaxation of (À) fat murine renal artery rings by R-L3. Vessels were isolated from wild-type (Kcnq1 +/+) mice. Arteries were precontracted by 1 μM phenylephrine (PE) or 60 mM KCl. Tension is expressed as a percentage of KCl or PE induced contractions. *, P < 0.05. n = 5 per group. ; n = 6 for Kcnq1À/À) and Kcnq5 expression (panel C) (n = 5 for Kcnq1 +/+ ; n = 5 for Kcnq1 À/À ).
n.s., P > 0.05, unpaired t-test. Figure S7 PCR genotyping of Kcnq1 +/+ and Kcnq1 À/À mice.
Amplification by using the forward and reverse primers gives a 240-bp product specific to the wild-type (+/+) allele. Amplification by using the Neo forward and reverse primers gives a 370-bp product specific to the null allele (À/À) (Casimiro et al., 2001) . Video S8 Demonstration of shaker-waltzer phenotype (hyperactivity, head shaking, and/or circling), due to abnormality of the vestibular apparatus in Kcnq1 À/À mice. The video shows the typical behaviour of lack of K V 7.1 channel function in the mouse.
